These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11309253)

  • 21. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addiction-related interactions of pregabalin with morphine in mice and humans: reinforcing and inhibiting effects.
    Vashchinkina E; Piippo O; Vekovischeva O; Krupitsky E; Ilyuk R; Neznanov N; Kazankov K; Zaplatkin I; Korpi ER
    Addict Biol; 2018 May; 23(3):945-958. PubMed ID: 28741741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin ETA receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice.
    Bhalla S; Pais G; Tapia M; Gulati A
    Can J Physiol Pharmacol; 2015 Nov; 93(11):935-44. PubMed ID: 26440527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
    Cook SA; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
    Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
    Romero EM; Fernández B; Sagredo O; Gomez N; Urigüen L; Guaza C; De Miguel R; Ramos JA; Viveros MP
    Brain Res Dev Brain Res; 2002 Jun; 136(2):85-92. PubMed ID: 12101025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine.
    Singh ME; Verty AN; McGregor IS; Mallet PE
    Brain Res; 2004 Nov; 1026(2):244-53. PubMed ID: 15488486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
    Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
    Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice.
    Anggadiredja K; Yamaguchi T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2003 Mar; 966(1):47-53. PubMed ID: 12646307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z; Han H; Cao J; Xu L
    Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
    García-Fuster MJ; Miralles A; García-Sevilla JA
    Neuropsychopharmacology; 2007 Feb; 32(2):399-411. PubMed ID: 16482086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine-induced conditioned place preference in rats is inhibited by electroacupuncture at 2 Hz: role of enkephalin in the nucleus accumbens.
    Liang J; Ping XJ; Li YJ; Ma YY; Wu LZ; Han JS; Cui CL
    Neuropharmacology; 2010 Jan; 58(1):233-40. PubMed ID: 19596017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.